PLATINUMS
What it found
No result yet.
What was tested
Treatment tested
- Telerehabilitation
Compared with
- Paper-based exercise
What it measured
Main measures
30 second sit to stand test
Baseline to 10 weeks
Walking and mobilityPhysical function
Other measures (15)
Short Physical Performance Battery
Baseline to 10 weeks
Walking and mobilityPhysical functionFunctional Reach Test
Baseline to 10 weeks
Timed 25 feet foot walk test
Baseline to 10 weeks
Disability progressionWalking and mobilityMiniBESTest
Baseline to 10 weeks
Walking and mobilitySix minute walk test
Baseline to 10 weeks
Walking and mobilityModified Fatigue Impact Scale
Baseline
FatigueQuality of life (reported by participants)12 item Multiple Sclerosis Walking Scale
Baseline to 10 weeks
Walking and mobilityQuality of life (reported by participants)Multiple Sclerosis Impact Scale
Baseline to 10 weeks
Quality of life (reported by participants)EQ-5D-5L
Baseline to 10 weeks
Quality of life (reported by participants)State-Trait Anxiety Inventory
Baseline to 10 weeks
Mood and sleepQuality of life (reported by participants)
Who could take part
MS (type not specified) · 18 and over
Inclusion Criteria: * Definite diagnosis of MS according to the McDonald criteria (both relapse-remitting and progressive) * Expanded Disability Status Scale (EDSS) score of 2.5 to 6.5 or Patient Determined Disability Score (PDDS) of 2 to 6, indicating preservation of at least some ambulatory function, that is, the ability to walk 20 meters or more, independently, with or without the use of an assistive device * Willingness to travel to the local study site for the evaluation sessions, * Internet platform availability Exclusion Criteria: * comorbidities hindering participation in the study. * Individuals who have had a documented relapse and/or corticoid treatment during the past three months will be excluded, * Individuals with severe cognitive deficits who cannot follow simple instructions and/or consent.
As registered. Criteria can change, so ask the trial team or your neurologist.
Contact details on the registryAbout this trial
In the sponsor's words
The overall purpose of the present study is to investigate the effect of an advanced telerehablitation system (TRS) in persons with multiple sclerosis on mobility. The advanced telerhabilitation system is based on AI components, and delivers instant feedback to the partcipants. If the project is successful, it can help optimize exercise for those persons with multiple sclerosis who are either not able or willing to travel to a clinical setting for exericse.
Papers
Loading reviews and guidelines…
History
Started
Feb 2026
Main results due
Dec 2026
Finished
Jul 2027
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error